Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors

Published:2022-10 Issue:10 Volume:33 Page:1041-1051
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Peyraud F.,Guégan J.-P.,Bodet D.,Nafia I.,Fontan L.,Auzanneau C.,Cousin S.,Roubaud G.,Cabart M.,Chomy F.,Le Loarer F.,Chaput N.,Danlos F.-X.,Planchard D.,Even C.,Khettab M.,Tselikas L.,Besse B.,Barlesi F.,Soria J.-C.,Marabelle A.,Bessede A.,Italiano A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference29 articles.

1. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

2. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

3. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy;Havel;Nat Rev Cancer,2019

4. The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors;Davis;J Immunother Cancer,2019

5. Modulation of cancer-specific immune responses by amino acid degrading enzymes;Timosenko;Immunotherapy,2017

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment;Biomarker Research;2024-09-03

2. Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes;Trends in Cancer;2024-09

3. Biomarkers to predict efficacy of immune checkpoint inhibitors in colorectal cancer patients: a systematic review and meta-analysis;Clinical and Experimental Medicine;2024-07-03

4. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome;Cell;2024-06

5. Engineered bacteria in tumor immunotherapy;Cancer Letters;2024-05